Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lumexa Imaging HoldingsLMRI +5.29%9 Equity-to-Asset is 0.34 as of Mar. 2026, which is 183% above its 10-year median of 0.12. GuruFocus rates LMRI with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 80.66% on this metric.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Lumexa Imaging Holdings Equity-to-Asset Related Terms
Lumexa Imaging Holdings Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LMRI vs QDEL, PRCT, AVNS: Equity-to-Asset Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Lumexa Imaging Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a Equity-to-Asset of 0.34 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Lumexa Imaging Holdings and its competitors. This is 183% above median its historical median of 0.12. Over the past decade, Lumexa Imaging Holdings' Equity-to-Asset has ranged from 0.10 to 0.34. According to the industry distribution chart, Lumexa Imaging Holdings ranks #688 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 80.7%.
Is Lumexa Imaging Holdings' Equity-to-Asset too high?
Lumexa Imaging Holdings' current Equity-to-Asset of 0.34 is 183% above median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.34. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Lumexa Imaging Holdings' value of 0.34 is 46.9% below this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #688 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumexa Imaging Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' Equity-to-Asset compare to QDEL and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #688 out of 853 companies for Equity-to-Asset. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Lumexa Imaging Holdings' value of 0.34 is 46.9% below this benchmark. Historically, Lumexa Imaging Holdings' own Equity-to-Asset has ranged from 0.10 to 0.34 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 0.64, Lumexa Imaging Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current Equity-to-Asset of 0.34 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current Equity-to-Asset is 0.34, which is 183% above median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current Equity-to-Asset of 0.34. The current Equity-to-Asset is 0.34, which is 183% above median its 10-year median of 0.12 and 46.9% below the Medical Devices & Instruments industry median of 0.64. Lumexa Imaging Holdings' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current Equity-to-Asset is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
9GF Score
Get the complete analysis for LMRI
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 
